1. Home
  2. WH vs GRFS Comparison

WH vs GRFS Comparison

Compare WH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wyndham Hotels & Resorts Inc.

WH

Wyndham Hotels & Resorts Inc.

HOLD

Current Price

$80.03

Market Cap

5.7B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.87

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WH
GRFS
Founded
2017
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.2B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
WH
GRFS
Price
$80.03
$8.87
Analyst Decision
Buy
Hold
Analyst Count
13
2
Target Price
$94.04
$10.15
AVG Volume (30 Days)
996.7K
485.7K
Earning Date
02-11-2026
07-28-2022
Dividend Yield
2.04%
1.60%
EPS Growth
38.00
N/A
EPS
4.33
0.64
Revenue
$1,436,000,000.00
$8,821,017,248.00
Revenue This Year
$5.20
$5.36
Revenue Next Year
$5.89
$5.15
P/E Ratio
$18.51
$17.46
Revenue Growth
3.83
7.31
52 Week Low
$69.21
$6.19
52 Week High
$113.07
$11.14

Technical Indicators

Market Signals
Indicator
WH
GRFS
Relative Strength Index (RSI) 57.57 44.66
Support Level $78.57 $8.79
Resistance Level $81.48 $9.40
Average True Range (ATR) 2.23 0.24
MACD 0.15 -0.05
Stochastic Oscillator 80.54 12.18

Price Performance

Historical Comparison
WH
GRFS

About WH Wyndham Hotels & Resorts Inc.

As of June 30, 2025, Wyndham Hotels & Resorts operates 846,700 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands, as of the end of 2024. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms, as of the end of 2024.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: